In conclusion, we demonstrated that DR6 stimulates AKT/NF-κB pathway to promote the malignant features of CRC cells, including the enhancement of cell proliferation, migration, invasion, and cell stemness. The gene discussed is NFKB1; the disease is colorectal carcinoma.